X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (166) 166
humans (157) 157
hematology (134) 134
oncology (108) 108
female (85) 85
male (84) 84
aged (82) 82
middle aged (77) 77
myelodysplastic syndromes (75) 75
hematology, oncology and palliative medicine (60) 60
prognosis (56) 56
myelodysplastic syndromes - drug therapy (50) 50
adult (48) 48
aged, 80 and over (43) 43
treatment outcome (43) 43
acute myeloid-leukemia (40) 40
leukemia (34) 34
mds (34) 34
myelodysplastic syndromes - mortality (34) 34
cancer (33) 33
care and treatment (31) 31
lenalidomide (31) 31
myelodysplastic syndromes - genetics (31) 31
retrospective studies (30) 30
survival (30) 30
azacitidine (29) 29
myelodysplastic syndrome (29) 29
risk (28) 28
article (27) 27
myelodysplastic syndromes - diagnosis (27) 27
myelodysplastic syndromes - pathology (27) 27
myelodysplastic syndromes - therapy (27) 27
risk factors (26) 26
abridged index medicus (25) 25
scoring system (25) 25
therapy (25) 25
thalidomide - analogs & derivatives (24) 24
mutation (23) 23
classification (22) 22
antimetabolites, antineoplastic - therapeutic use (21) 21
azacitidine - therapeutic use (21) 21
hemic and lymphatic diseases (21) 21
survival analysis (21) 21
antineoplastic agents - therapeutic use (20) 20
prognostic scoring system (20) 20
young adult (20) 20
mutations (19) 19
analysis (18) 18
decitabine (18) 18
anemia (17) 17
disease progression (17) 17
research (17) 17
survival rate (17) 17
thalidomide - therapeutic use (17) 17
world-health-organization (17) 17
chronic myelomonocytic leukemia (16) 16
chromosome deletion (15) 15
development and progression (15) 15
efficacy (15) 15
myelofibrosis (15) 15
acute myelogenous leukemia (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
leukemia, myeloid, acute - drug therapy (14) 14
genetic aspects (13) 13
international working group (13) 13
leukemia, myeloid, acute - mortality (13) 13
medicine & public health (13) 13
acute myeloid leukemia (12) 12
chemotherapy (12) 12
disease-free survival (12) 12
hematopoietic stem cell transplantation (12) 12
hypomethylating agents (12) 12
remission induction (12) 12
treatment failure (12) 12
myelodysplastic syndromes - classification (11) 11
quality-of-life (11) 11
ruxolitinib (11) 11
stem-cell transplantation (11) 11
transplantation (11) 11
transplantation, homologous (11) 11
adolescent (10) 10
aml (10) 10
antineoplastic agents - adverse effects (10) 10
azacitidine - analogs & derivatives (10) 10
cytogenetics (10) 10
essential thrombocythemia (10) 10
follow-up studies (10) 10
impact (10) 10
kaplan-meier estimate (10) 10
myeloproliferative neoplasms (10) 10
patients (10) 10
transfusion-dependent patients (10) 10
united states (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
case-control studies (9) 9
clinical trials (9) 9
clinical trials as topic (9) 9
immunologic factors - therapeutic use (9) 9
leukemia, myeloid, acute - pathology (9) 9
myelodysplastic syndromes - complications (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Hematologic Malignancy Reports, ISSN 1558-8211, 8/2019, Volume 14, Issue 4, pp. 346 - 351
Alleviating cytopenias, namely anemia, is the main goal of therapy in lower-risk myelodysplastic syndromes (MDS). Current available treatment options remain... 
Medicine & Public Health | Hematology | Geriatrics/Gerontology | Oncology | TGFB Pathway | Erythroid Maturation Agents | MDS | PLACEBO | ACE-536 | SOTATERCEPT ACE-011 | ACTRIIA-IGG1 | PHASE-2 | ONCOLOGY | LENALIDOMIDE | SCORING SYSTEM | ANEMIA | HEMATOLOGY | MYELODYSPLASTIC SYNDROMES | Transforming growth factors | Anemia
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2956 - 2956
Introduction: Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) is defined by the presence of a concomitant hematologic malignancy with... 
Journal Article
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting, 2016, Volume 35, Issue 36, pp. e345 - e352
Hypomethylating agents (HMAs) are the mainstay treatment of patients with myelodysplastic syndromes. Hypomethylating agents remain the only treatment, other... 
Journal Article
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2016, Volume 35, p. e345
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 1, pp. 112 - 121
Summary Background Clonal haemopoiesis of indeterminate potential (CHIP) is an age-associated genetic event linked to increased risk of primary haematological... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | BREAST-CANCER | COLON-CANCER | VARIANTS | ONCOLOGY | FORMAT | SEQUENCE | MUTATIONS | LEUKEMIA | OUTCOMES | MYELODYSPLASTIC SYNDROMES | Clone Cells - drug effects | Prognosis | Follow-Up Studies | Humans | Leukemia, Myeloid, Acute - epidemiology | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Case-Control Studies | Incidence | Neoplasms, Second Primary - chemically induced | Myelodysplastic Syndromes - chemically induced | Aged, 80 and over | Female | Neoplasms, Second Primary - genetics | High-Throughput Nucleotide Sequencing - methods | Leukemia, Myeloid, Acute - chemically induced | Florida - epidemiology | Risk Factors | Hematopoiesis - genetics | Survival Rate | Mutation - genetics | Myelodysplastic Syndromes - epidemiology | Clone Cells - metabolism | Neoplasms - drug therapy | Neoplasms, Second Primary - diagnosis | Neoplasms, Second Primary - epidemiology | Myelodysplastic Syndromes - diagnosis | Clone Cells - pathology | Leukemia, Myeloid, Acute - diagnosis | Aged | Biomarkers, Tumor - genetics | Myelodysplastic Syndromes - genetics | Neoplasm Staging | Neoplasms - pathology | Leukemia, Myeloid, Acute - genetics | Care and treatment | Chemotherapy | Oncology, Experimental | Mortality | Aged patients | Research | Epidemiology | Cancer | Development and progression
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5442 - 5442
Introduction Chronic myelomonocytic leukemia (CMML) is an overlap syndrome with both myeloproliferative and myelodysplastic features. Clinical outcomes can be... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4383 - 4383
Abstract CONTEXT AND OBJECTIVE: Refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) is a provisional entity included in the MDS/MPN overlap... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2361 - 2361
Abstract CONTEXT: Evidence is lacking to guide patients diagnosed with acute myeloid leukemia and high-risk myelodysplastic syndrome in selecting the best... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4244 - 4244
Background: Myelodysplastic syndrome with ring sideroblasts (MDS-RS) is defined by the World Health Organization (WHO) as ring sideroblasts (RS) ≥15% or ≥5%... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5428 - 5428
Introduction: Advanced molecular profiling with next generation sequencing (NGS) has greatly improved the diagnostic and prognostic stratification of... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1717 - 1717
Introduction: CMML is a heterogenous myeloid neoplasm with an estimated median overall survival (OS) of 31 months with 20% of patients transforming to acute... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4177 - 4177
Introduction: Primary and secondary myelofibrosis (MF) [i.e. occurring after a prior diagnosis of polycythemia vera [PV] or essential thrombocythemia (ET)] are... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3001 - 3001
Introduction Recurrent somatic mutations (SM) of the splicing factor 3B subunit 1 (SF3B1) are among the most commonly occurring in MDS patients (pts), detected... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.